Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

National Parkinson Foundation Expands Expert Care Network in Italy

MIAMI — The National Parkinson Foundation (NPF), a division of the Parkinson’s Foundation, announced today a new partnership with the Fresco Institute Italia to improve the quality of Parkinson’s care in Italy. The NPF Center of Excellence global network embodies the world’s leading Parkinson’s specialists focused on changing the course of Parkinson’s disease (PD). 

“The NPF Center of Excellence program is more than just a designation, it represents a philosophy of care that focuses on achieving the best we can for patients today while working to improve care for tomorrow,” said Peter Schmidt, NPF’s Senior Vice President and Chief Mission Officer.  “Working with the Fresco Institute Italia, we hope to bring this philosophy of the best care for people with Parkinson’s today to the centers guiding care in Italy.”

NPF Centers of Excellence are designated after a rigorous application and peer-review process. They collaborate on a program of continuous improvement through the Parkinson’s Outcomes Project, the largest clinical study of Parkinson’s ever conducted. This network of over 40 academic medical centers link cutting-edge research to exemplar patient-focused clinical care.  By linking research and care, the Centers of Excellence network is both a proving ground for new therapies and creating the evidence that guides the care that today’s patients receive. The network reflects NPF’s ongoing commitment to promoting greater access to expert care.

Working together, NPF and Fresco Network leadership will develop and launch programs to improve patient outcomes in Italy that builds upon the unique insight and expertise of Parkinson’s experts in Italy together with leading clinicians from around the world.

“Bringing together our great teams offers us the opportunity to share our visions in developing a comprehensive plan to improve care in Italy, and also to share our unique insight with the world-wide NPF network,” said Paolo Fresco, Founder of the Fresco Institute Italia.

NPF’s Center of Excellence network features world-renowned Parkinson’s specialists focused on reaching across patient and professional communities to change the course of Parkinson’s disease. The network serves more than 100,000 individuals diagnosed with Parkinson’s. In order to participate in the competitive designation process, centers must first meet strict criteria for research, comprehensive care, patient outreach services and professional education.  The NPF Center of Excellence network is widely credited with developing and promoting the modern Parkinson’s team model of care and ensuring patients the highest standards of care.

NPF brings all Centers of Excellence together annually to provide updates on care activities and research initiatives. Each NPF Center of Excellence must re-certify every five years in order to ensure that they maintain high standards of care. This process includes a review of achievements as well as a team-based peer evaluation including an on-site assessment.

About Parkinson's Disease (PD)

Parkinson's disease is a progressive neurological disorder that affects nearly one million people in the US and over 10 million worldwide.  Parkinson's is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the US.  It is associated with a loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety).  Although promising research is being conducted, there is currently no cure for Parkinson's disease.

About the Fresco Institute Italia

The Fresco Institute Italia was created in 2015 to coordinate the activities of Italian centers dedicated to research and treatment of movement disorders with the activities of the Fresco Institute at NYU Langone Medical Center. Its main aim is to build a network of excellence in Italy, creating highly qualified centers that meet the criteria established by the National Parkinson Foundation. This objective will be achieved through promotion of joint research projects, exchanges, transfer of scientific information and new clinical treatments, training opportunities for young neurologists and scientists who want to specialize in the field of Parkinson and movement disorders. The synergies and the collaborations that distinguish the Fresco Institute Italia were created thanks to the vision, passion and support of Paolo and Marlene Fresco. For information about the Fresco Institute Italia, visit www.frescoinstituteitalia.it.

Wednesday, November 2, 2016
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.